Vicki Durston, Director of Policy and Advocacy at Breast Cancer Network Australia (BCNA), shared a post by Breast Cancer Network Australia, adding:
“Reflecting on an extraordinary week at ESMO Breast Cancer Congress 2026 in Berlin before discussions continue this week in the UK Parliament with international collaborators and partners.
The pace of innovation in breast cancer care is accelerating rapidly – reinforcing how important it is that health systems, medicines access pathways and policy frameworks evolve alongside the science.
What became increasingly clear throughout ESMO is that breast cancer care is changing fundamentally. As treatments become more personalised and people live longer with increasingly complex disease pathways, the way we deliver oncology care, supportive care, information, survivorship services and policy reform cannot remain stagnant.
We are approaching a turning point in cancer care globally.
Proud that BCNA could contribute to these important conversations through our work on metastatic breast cancer data visibility, access to medicines and consumer leadership.”
Quoting Breast Cancer Network Australia‘s post:
“Last year, BCNA led the advocacy around the first official estimate of Australians living with metastatic breast cancer – 20,950.
Last week, we shared that information at the largest international breast cancer conference – European Society for Medical Oncology Breast Cancer – in the hope that other countries follow Australia’s lead.
Australia’s count is double previous estimates – highlighting how crucial it is for policy makers to have access to the right data to plan, fund and deliver equitable care.
This means that people with metastatic breast cancer can get the treatment, support and care they need – when and where they need it.
Click the link to read more.”